Hongyan Guo
Papers
1
Total Citations
2
H-Index
1
About
Hongyan Guo is a pioneering figure in gynecologic oncology and robotic surgery, renowned for advancing minimally invasive techniques in the treatment of gynecologic cancers. Her research focuses on evaluating the efficacy and safety of novel surgical platforms, particularly in endometrial cancer management. Guo’s landmark work includes a multi-center, randomized, noninferiority trial comparing the KangDuo Surgical Robot-01 (KD-SR-01) with the da Vinci Xi system for endometrial cancer surgery, a study that has already garnered significant attention with 2 citations shortly after its 2025 publication. This trial represents a critical contribution to the field, demonstrating that domestic robotic systems can match the performance of established international platforms, potentially expanding access to robotic surgery. Guo’s research has profound implications for surgical oncology, offering evidence that could reshape clinical practice and reduce healthcare disparities. Her work underscores her commitment to rigorous clinical evaluation and innovation, positioning her as a key voice in the future of robotic-assisted gynecologic surgery.
Research Focus
Key Achievements
Top Papers
- 1